Table 1

Seroprevalence of transfusion transmittable infections among donor blood samples

YearTested donors
(no)
Hepatitis B (%)Hepatitis C (%)Syphilis (%)Total positive results (%)Total donors with positive results (%)Total tested
2019Male donors
(70268)
1086
(1.54)
96
(0.13)
264
(0.37)
1446
(2.1)
1552
(2.1)
70 351
Female donors
(83)
0
(0)
1
(1.2)
5
(6)
6
(7.2)
2020Male donors
(57814)
838
(1.45)
70
(0.12)
272
(0.47)
1180
(2.04)
1181
(2.04)
57 860
Female donors
(46)
0
(0)
0
(0)
1
(2.2)
1
(2.2)
2021Male donors
(69566)
795
(1.14)
76
(0.11)
248
(0.36)
1119
(1.61)
1123
(1.61)
69 651
Female donors
(85)
1
(1.2)
1
(1.2)
2
(2.4)
4
(4.7)
Tested donors within 3 years
(%)
Male donors
197 684
(99.9)
2719
(1.38)
242
(0.12)
784
(0.4)
3745
(1.89)
3756
(1.9)
197 898
Female donors
214
(0.1)
1
(0.46)
2
(0.93)
8
(3.7)
11
(5.14)
Total donors with positive results (%)2720
(1.374)
244
(0.123)
792
(0.4)
  • Out of 197898 tested donors, 3756 (1.9%) showed a positive result for at least one screening test (Hepatitis C, Syphilis) during the three-year period.